Screener
Idexx Laboratories IDXX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Idexx Laboratories’s 8-K, filed August 4, 2026. Open the filing →
- Filed
- Aug 4, 2026, 6:32 AM EDT
- Accession
- 0001104659-26-090033
FAQ
- What is Idexx Laboratories's EPS (diluted)?
- Idexx Laboratories (IDXX) reported EPS (diluted) of $4.27 in Q2 2026.
- How has Idexx Laboratories's EPS (diluted) changed year-over-year?
- Idexx Laboratories's EPS (diluted) increased by 17.6% year-over-year, from $3.63 to $4.27.
- What is the long-term trend for Idexx Laboratories's EPS (diluted)?
- Over 4 years (2021 to 2025), Idexx Laboratories's EPS (diluted) has grown at a 11.0% compound annual growth rate (CAGR), from $8.61 to $13.08.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Idexx Laboratories's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude